Syed Kazmi, MD, an oncologist at The University of Texas Southwestern Medical Center, discusses key treatment considerations for young patients with onset colorectal cancer.
Syed Kazmi, MD
Advertisement
Articles by Syed Kazmi, MD
Syed Kazmi, MD, discusses the importance of tailoring treatment to different subtypes of colorectal cancer.
Syed Kazmi, MD, discusses emerging biomarkers that could help guide treatment decisions in patients with colorectal cancer.
Syed Kazmi, MD, discusses choosing among regorafenib and TAS-102 in the treatment of patients with metastatic colorectal cancer.
Syed Kazmi, MD, discusses differences between left- and right-sided tumors in patients with colorectal cancer.
Advertisement
Latest Updated Articles
Dr. Kazmi on Key Treatment Considerations for Young-Onset CRCPublished: May 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
The OncFive: Top Oncology Articles for the Week of 1/25
3
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
4
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
5